|
Volumn 35, Issue 3 SUPPL., 2003, Pages S67-S72
|
Optimizing the long-term outcome of renal transplants: Opportunities created by sirolimus
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOSTEROID;
CYCLOSPORIN;
RAPAMYCIN;
ADULT;
CHRONIC KIDNEY DISEASE;
CLINICAL TRIAL;
COHORT ANALYSIS;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ELIMINATION;
DRUG WITHDRAWAL;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HERPES ZOSTER;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERLIPIDEMIA;
IMMUNE RESPONSE;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY FUNCTION;
KIDNEY TRANSPLANTATION;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
MALE;
NEPHROTOXICITY;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PNEUMONIA;
PRIORITY JOURNAL;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
SKIN CARCINOMA;
TREATMENT OUTCOME;
|
EID: 0037961778
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(03)00236-7 Document Type: Conference Paper |
Times cited : (11)
|
References (16)
|